GBM AGILE adaptive clinical trial is open and currently enrolling patients. If you’d like to find a trial near you, please visit clinicaltrials.gov and use the trial identifier number–NCT03970447.
If you have questions regarding GBM AGILE please contact Hali Hartman, Director of Scientific Relations at email@example.com or 1-800-321-CURE (2873).
The support of our donors is crucial to the continued success of GBM AGILE. If you’d like to be a part of our movement to save the lives of those diagnosed with GBM, please consider a gift to GBM AGILE today. Charitable support can be made by check, credit card, stocks, IRA transfers and through donor advised funds, private foundations and charitable trusts.